Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 May;71(5):1366–1374. doi: 10.1172/JCI110889

Nonadrenergic effects of isoproterenol in dogs with hypoxic pulmonary vasoconstriction. Possible role of prostaglandins.

L J Rubin, J D Lazar
PMCID: PMC437000  PMID: 6406548

Abstract

To determine whether the pulmonary vasodilation produced by isoproterenol is mediated solely by its beta adrenergic effects, we studied the hemodynamic responses to isoproterenol in three groups of dogs with pulmonary vasoconstriction produced by continuous ventilation with 10% oxygen: (a) hypoxia alone, (b) hypoxia and propranolol 0.3 mg/kg i.v. bolus followed by an infusion of 5 micrograms/kg per min, and (c) hypoxia after pretreatment with an inhibitor of cyclooxygenase, either indomethacin or meclofenamate 5 mg/kg s.c. twice daily for 2 d prior to study. All groups had similar values for mean pulmonary artery pressure (PAPm) and pulmonary vascular resistance (PVR) during room air and hypoxic ventilation. Isoproterenol in doses of 0.0025, 0.005, and 0.05 micrograms/kg per min produced a dose-related decline in PAPm and PVR during hypoxia in group 1. Despite beta-blockade with propranolol (group 2), isoproterenol at all three doses significantly reduced PAPm and PVR. The responses to isoproterenol were comparable in the presence or absence of propranolol; at 0.05 micrograms/kg per min the effects of isoproterenol were blunted, but not abolished, by propranolol. Similar results were observed even when five times the dose of propranolol was given. Isoproterenol at all three doses had no effect, however, on PAPm and PVR in the cyclooxygenase inhibitor-pretreated group. These data suggest that the pulmonary vasodilator effects of isoproterenol are not mediated solely by pulmonary vascular beta adrenergic receptors, and that vasodilator prostaglandins may play a role in the responses to this drug.

Full text

PDF
1366

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J. M., Nyby M. D., Jasberg K. A. Prostaglandin synthesis inhibition restores hypoxic pulmonary vasoconstriction. J Appl Physiol Respir Environ Exerc Physiol. 1977 Jun;42(6):903–908. doi: 10.1152/jappl.1977.42.6.903. [DOI] [PubMed] [Google Scholar]
  2. Barer G. R., McCurrie J. R. Pulmonary vasomotor responses in the cat; the effects and interrelationships of drugs, hypoxia and hypercapnia. Q J Exp Physiol Cogn Med Sci. 1969 Apr;54(2):156–172. doi: 10.1113/expphysiol.1969.sp002014. [DOI] [PubMed] [Google Scholar]
  3. Barer G. R. Reactivity of the vessels of collapsed and ventilated lungs to drugs and hypoxia. Circ Res. 1966 Apr;18(4):366–378. doi: 10.1161/01.res.18.4.366. [DOI] [PubMed] [Google Scholar]
  4. Benumof J. L., Wahrenbrock E. A. Local effects of anesthetics on regional hypoxic pulmonary vasoconstriction. Anesthesiology. 1975 Nov;43(5):525–532. doi: 10.1097/00000542-197511000-00008. [DOI] [PubMed] [Google Scholar]
  5. Bjertnaes L. J. Hypoxia-induced vasoconstriction in isolated perfused lungs exposed to injectable or inhalation anesthetics. Acta Anaesthesiol Scand. 1977;21(2):133–147. doi: 10.1111/j.1399-6576.1977.tb01203.x. [DOI] [PubMed] [Google Scholar]
  6. Brody M. J., Kadowitz P. J. Prostaglandins as modulators of the autonomic nervous system. Fed Proc. 1974 Jan;33(1):48–60. [PubMed] [Google Scholar]
  7. Campbell W. B., Graham R. M., Jackson E. K. Role of renal prostaglandins in sympathetically mediated renin relase in the rat. J Clin Invest. 1979 Aug;64(2):448–456. doi: 10.1172/JCI109482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cleaveland C. R., Rangno R. E., Shand D. G. A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol. Arch Intern Med. 1972 Jul;130(1):47–52. doi: 10.1001/archinte.130.1.47. [DOI] [PubMed] [Google Scholar]
  9. Coltart D. J., Shand D. G. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man. Br Med J. 1970 Sep 26;3(5725):731–734. doi: 10.1136/bmj.3.5725.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Daly I. D., Michel C. C., Ramsay D. J., Waaler B. A. Conditions governing the pulmonary vascular response to ventilation hypoxia and hypoxaemia in the dog. J Physiol. 1968 May;196(2):351–379. doi: 10.1113/jphysiol.1968.sp008512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. FISHMAN A. P. Respiratory gases in the regulation of the pulmonary circulation. Physiol Rev. 1961 Jan;41:214–280. doi: 10.1152/physrev.1961.41.1.214. [DOI] [PubMed] [Google Scholar]
  12. Fishman A. P. Hypoxia on the pulmonary circulation. How and where it acts. Circ Res. 1976 Apr;38(4):221–231. doi: 10.1161/01.res.38.4.221. [DOI] [PubMed] [Google Scholar]
  13. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974 Mar;26(1):33–67. [PubMed] [Google Scholar]
  14. Gerber J. G., Branch R. A., Nies A. S., Gerkens J. F., Shand D. G., Hollifield J., Oates J. A. Prostaglandins and renin release: II. Assessment of renin secretion following infusion of PGI2,E2 and D2 into the renal artery of anesthetized dogs. Prostaglandins. 1978 Jan;15(1):81–88. doi: 10.1016/s0090-6980(78)80006-9. [DOI] [PubMed] [Google Scholar]
  15. Greenberg S., Engelbrecht J. A., Wilson W. R. The role of the autonomic nervous system in the responses of the perfused canine paw to prostaglandins B1 and B2. J Pharmacol Exp Ther. 1974 Apr;189(1):130–139. [PubMed] [Google Scholar]
  16. Hamberg M. Inhibition of prostaglandin synthesis in man. Biochem Biophys Res Commun. 1972 Nov 1;49(3):720–726. doi: 10.1016/0006-291x(72)90470-6. [DOI] [PubMed] [Google Scholar]
  17. Hyman A. L., Kadowitz P. J. Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat. Circ Res. 1979 Sep;45(3):404–409. doi: 10.1161/01.res.45.3.404. [DOI] [PubMed] [Google Scholar]
  18. Kadowitz P. J., Joiner P. D., Hyman A. L., George W. J. Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels. J Pharmacol Exp Ther. 1975 Mar;192(3):677–687. [PubMed] [Google Scholar]
  19. Kadowitz P. J., Sweet C. S., Brody M. J. Influence of prostaglandins on adrenergic transmission to vascular smooth muscle. Circ Res. 1972 Sep;31(9 Suppl):36–50. doi: 10.1007/978-1-4684-2844-5_23. [DOI] [PubMed] [Google Scholar]
  20. Leffler C. W., Hessler J. R. Pulmonary and systemic vascular effects of exogenous prostaglandin I2 in fetal lambs. Eur J Pharmacol. 1979 Feb 15;54(1-2):37–42. doi: 10.1016/0014-2999(79)90405-9. [DOI] [PubMed] [Google Scholar]
  21. Lloyd T. C., Jr Role of nerve pathways in the hypoxic vasoconstriction of lung. J Appl Physiol. 1966 Jul;21(4):1351–1355. doi: 10.1152/jappl.1966.21.4.1351. [DOI] [PubMed] [Google Scholar]
  22. Malik A. B., Kidd B. S. Adrenergic blockade and the pulmonary vascular response to hypoxia. Respir Physiol. 1973 Oct;19(1):96–106. doi: 10.1016/0034-5687(73)90093-5. [DOI] [PubMed] [Google Scholar]
  23. Malik K. U. Prostaglandin-mediated inhibition of the vasoconstrictor responses of the isolated perfused art splenic vasculature to adrenergic stimuli. Circ Res. 1978 Aug;43(2):225–233. doi: 10.1161/01.res.43.2.225. [DOI] [PubMed] [Google Scholar]
  24. Nation R. L., Peng G. W., Chiou W. L. High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma. J Chromatogr. 1978 May 1;145(3):429–436. doi: 10.1016/s0378-4347(00)81372-9. [DOI] [PubMed] [Google Scholar]
  25. Porcelli R. J., Bergofsky E. H. Adrenergic receptors in pulmonary vasoconstrictor responses to gaseous and humoral agents. J Appl Physiol. 1973 Apr;34(4):483–488. doi: 10.1152/jappl.1973.34.4.483. [DOI] [PubMed] [Google Scholar]
  26. Reeves J. T., Wagner W. W., Jr, McMurtry I. F., Grover R. F. Physiological effects of high altitude on the pulmonary circulation. Int Rev Physiol. 1979;20:289–310. [PubMed] [Google Scholar]
  27. Rubin L. J., Lazar J. D. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction. J Clin Invest. 1981 Jan;67(1):193–200. doi: 10.1172/JCI110012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shand D. G., Evans G. H., Nies A. S. The almost complete hepatic extraction of propranolol during intravenous administration in the dog. Life Sci I. 1971 Dec 15;10(24):1417–1421. doi: 10.1016/0024-3205(71)90271-2. [DOI] [PubMed] [Google Scholar]
  29. Silove E. D., Grover R. F. Effects of alpha adrenergic blockade and tissue catecholamine depletion on pulmonary vascular response to hypoxia. J Clin Invest. 1968 Feb;47(2):274–285. doi: 10.1172/JCI105724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Silove E. D., Inoue T., Grover R. F. Comparison of hypoxia, pH, and sympathomimetic drugs on bovine pulmonary vasculature. J Appl Physiol. 1968 Mar;24(3):355–365. doi: 10.1152/jappl.1968.24.3.355. [DOI] [PubMed] [Google Scholar]
  31. Starling M. B., Neutze J. M., Elliott R. L. Control of elevated pulmonary vascular resistance in neonatal swine with prostacyclin (PGI2). Prostaglandins Med. 1979 Aug;3(2):105–117. doi: 10.1016/0161-4630(79)90078-8. [DOI] [PubMed] [Google Scholar]
  32. Thilenius O. G., Candiolo B. M., Beug J. L. Effect of adrenergic blockade on hypoxia-induced pulmonary vasoconstriction in awake dogs. Am J Physiol. 1967 Oct;213(4):990–998. doi: 10.1152/ajplegacy.1967.213.4.990. [DOI] [PubMed] [Google Scholar]
  33. Unger M., Atkins M., Briscoe W. A., King T. K. Potentiation of pulmonary vasoconstrictor response with repeated intermittent hypoxia. J Appl Physiol Respir Environ Exerc Physiol. 1977 Oct;43(4):662–667. doi: 10.1152/jappl.1977.43.4.662. [DOI] [PubMed] [Google Scholar]
  34. Wennmalm A., Brundin T. Prostaglandin-mediated inhibition of noradrenaline release: IV. Prostaglandin synthesis is stimulated by myocardial adrenoceptors differing from the alpha- and beta-type. Acta Physiol Scand. 1978 Mar;102(3):374–381. [PubMed] [Google Scholar]
  35. Zwillich C. W., Martin B. J., Rose C. E. Relative selective action of propranolol on cardiovascular and respiratory responses to isoproterenol. Clin Pharmacol Ther. 1980 Apr;27(4):454–459. doi: 10.1038/clpt.1980.63. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES